| Product Name |
Avanafil-13C5,15N
|
| Product Code |
DA-A343-09
|
| Chemical name |
Avanafil-13C5,15N
|
| Synonyms |
(S)-2-(2-Hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylamino)-5-[(2-pyrimidinylmethyl)carbamoyl]pyrimidine-13C5,15N; TA 1790-13C5,15N; 4-[[(3-Chloro-4-methoxyphenyl)methyl] amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide-13C5,15N;
|
| Impurity |
NA
|
| CAS Number |
1276495-36-3
|
| Alternate CAS # |
NA
|
| Molecular form |
C1813C5H26ClN615NO3
|
| Appearance |
NA
|
| Melting Point |
NA
|
| Mol. Weight |
489.91
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
aromatics,chiral standards,heterocycles,pharmaceutical standards,intermediates,fine chemicals,stable isotopes
|
| Boiling Point |
NA
|
| Applications |
A labelled phosphodiesterase (PDE5) inhibitor, used to treat erectile dysfunction.
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
